IQVIA Holdings, Inc. (IQV): Price and Financial Metrics


IQVIA Holdings, Inc. (IQV)

Today's Latest Price: $149.39 USD

0.67 (-0.45%)

Updated Feb 26 4:10pm

Add IQV to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

IQV Stock Summary

  • Iqvia Holdings Inc's market capitalization of $30,923,767,690 is ahead of 93.23% of US-listed equities.
  • With a one year PEG ratio of 1,547.06, Iqvia Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.88% of US stocks.
  • IQV's current price/earnings ratio is 126.74, which is higher than 95.17% of US stocks with positive earnings.
  • Stocks that are quantitatively similar to IQV, based on their financial statements, market capitalization, and price volatility, are INFO, VRSK, CMG, SBAC, and HRL.
  • IQV's SEC filings can be seen here. And to visit Iqvia Holdings Inc's official web site, go to www.iqvia.com.
IQV Daily Price Range
IQV 52-Week Price Range

IQV Stock Price Chart More Charts


IQV Price/Volume Stats

Current price $149.39 52-week high $169.14
Prev. close $150.06 52-week low $130.77
Day low $148.94 Volume 1,667,780
Day high $154.37 Avg. volume 1,358,845
50-day MA $157.31 Dividend yield N/A
200-day MA $150.82 Market Cap 28.73B

IQVIA Holdings, Inc. (IQV) Company Bio


IQVIA provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The company was founded in 1982 and is based in Durham, North Carolina.

IQV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$149.39$75.44 -52%

Below please find a table outlining a discounted cash flow forecast for IQV, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Iqvia Holdings Inc ranked in the 34st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 52%. The most interesting components of our discounted cash flow analysis for Iqvia Holdings Inc ended up being:

  • Its compound free cash flow growth rate, as measured over the past 5.81 years, is 0.18% -- higher than 62.79% of stocks in our DCF forecasting set.
  • Relative to other stocks in its sector (Healthcare), Iqvia Holdings Inc has a reliance on debt greater than 73.52% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-53%
1%-53%
2%-52%
3%-52%
4%-51%
5%-51%

Want more companies with a valuation profile/forecast similar to that of Iqvia Holdings Inc? See HSIC, ABT, HCSG, LHCG, and JNJ.


IQV Latest News Stream


Event/Time News Detail
Loading, please wait...

IQV Latest Social Stream


Loading social stream, please wait...

View Full IQV Social Stream

IQV Price Returns

1-mo -4.94%
3-mo 1.27%
6-mo -3.71%
1-year 5.96%
3-year 92.41%
5-year 129.90%
YTD -3.31%
2019 33.00%
2018 18.66%
2017 28.73%
2016 10.76%
2015 16.63%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7546 seconds.